Recovery guide
Post-acute withdrawal syndrome (PAWS): symptoms, timeline and what helps
Post-acute withdrawal syndrome (PAWS) is the name for withdrawal-related symptoms, such as anxiety, low mood, irritability, poor sleep, trouble concentrating and cravings, that persist, come back or first appear after acute withdrawal has ended, often for weeks or months. It is not a formal diagnosis in the DSM, and the federal Substance Abuse and Mental Health Services Administration (SAMHSA) calls it protracted withdrawal (SAMHSA, 2010; Bahji et al., 2022). Jump to the symptom tracker.
- Also called
- Protracted withdrawal, or protracted abstinence.
- Common symptoms
- Anxiety, low mood, poor sleep, poor focus and cravings.
- How long
- Weeks to months; sleep changes after alcohol can last 1 to 3 years.
- Diagnosis
- Not in the DSM, and no agreed definition yet.
Reviewed against public records, . Sources: SAMHSA, U.S. Food and Drug Administration, National Library of Medicine (MedlinePlus), Journal of Studies on Alcohol and Drugs. Sources
What is post-acute withdrawal syndrome?
Post-acute withdrawal syndrome is a set of symptoms that persist, change or appear well past the expected end of acute withdrawal from alcohol or other drugs. SAMHSA's 2010 advisory on the subject uses the term protracted withdrawal and gives two definitions: a strict one, covering the same substance-specific signs as acute withdrawal lasting longer than usual, and a broader one that adds non-specific symptoms such as low mood and poor sleep (SAMHSA, 2010).
The same pattern goes by many names. SAMHSA lists ten, including postacute withdrawal syndrome, protracted abstinence, extended withdrawal, late withdrawal and subacute withdrawal (SAMHSA, 2010). Descriptions of "late withdrawal symptoms" after alcohol date back to 1954 (Bahji et al., 2022).
Why do the symptoms happen?
Long-term substance use changes the brain at the molecular, cellular and circuit level, and some of those changes outlast acute withdrawal. One example SAMHSA gives is anhedonia: repeated use makes the brain respond more to the substance and less to natural rewards such as music, so ordinary pleasures feel flat for a while after stopping (SAMHSA, 2010). A 2022 systematic review of 27 studies on alcohol linked post-acute symptoms to measured differences in stress hormones such as cortisol, in serotonin and in brain activity, and described adaptations in the nucleus accumbens and the prefrontal cortex as a proposed mechanism (Bahji et al., 2022).
How is PAWS different from acute withdrawal?
Acute withdrawal is a predictable set of physical signs that starts within hours or days of the last use and fades within days to a few weeks; PAWS is what lingers, mostly in mood, sleep and thinking, after that window closes. Acute signs tend to be the opposite of the drug's effects: pupils shrink during opioid intoxication and widen during opioid withdrawal (SAMHSA, 2010).
At a glance
Acute withdrawal and post-acute withdrawal, side by side
Acute withdrawal
- Starts within hours or days of the last use
- Mostly physical: shaking, sweating, nausea, insomnia
- Lasts days to a few weeks, depending on the substance
- Can be a medical emergency, especially after alcohol or benzodiazepines
Post-acute (protracted) withdrawal
- Persists, returns or begins after acute withdrawal ends
- Mostly mood, sleep, thinking and cravings
- Weeks to months, with no agreed timeframe
- Can come and go in intensity
Sources: SAMHSA Protracted Withdrawal advisory, 2010; MedlinePlus, Alcohol withdrawal, 2025; FDA, 2020
For a sense of scale, SAMHSA's approximate acute timeframes are 5 to 7 days for alcohol, 4 to 10 days for opioids (14 to 21 days for methadone), 1 to 2 weeks for stimulants, about 5 days for cannabis, and 1 to 4 weeks for benzodiazepines, or 3 to 5 weeks with a gradual taper (SAMHSA, 2010). Opioid withdrawal symptoms usually start within 12 hours of the last heroin use and within 30 hours of the last methadone dose (MedlinePlus, 2026).
Acute withdrawal can be dangerous
Alcohol withdrawal can quickly become life-threatening; call 911 for seizures, fever, severe confusion, hallucinations or an irregular heartbeat (MedlinePlus, 2025). Stopping a benzodiazepine abruptly, or cutting the dose too fast, can cause seizures; taper only on a plan made with the prescriber (FDA, 2020).
What are the symptoms of PAWS?
SAMHSA lists 13 possible symptoms of protracted withdrawal, led by anxiety, sleep difficulties, short-term memory problems, persistent fatigue and trouble concentrating. A 2022 review of alcohol studies named the same core group: anxiety, low mood (dysphoria), loss of pleasure (anhedonia), poor sleep, cognitive problems, cravings and irritability (SAMHSA, 2010; Bahji et al., 2022).

Nights that run short and days that feel foggy are typical. The following are the 13 possible symptoms in SAMHSA's advisory:
- Anxiety
- Sleep difficulties
- Problems with short-term memory
- Persistent fatigue
- Difficulty concentrating and making decisions
- Alcohol or drug cravings
- Impaired executive control, such as impulse control and problem solving
- Anhedonia, a reduced ability to feel pleasure
- Difficulty focusing on tasks
- Dysphoria or depression
- Irritability
- Unexplained physical complaints
- Reduced interest in sex
Do the symptoms differ by substance?
The symptoms are similar but not identical, because each substance class acts on the brain differently (SAMHSA, 2010).
- Alcohol
- Well documented: anxiety, hostility, irritability, depression, mood swings, fatigue, insomnia, poor concentration, reduced interest in sex and unexplained pain (SAMHSA, 2010).
- Opioids
- Anxiety, depression and sleep problems for weeks or months, plus fatigue, dysphoria and irritability; problems with focus and executive control can persist for months (SAMHSA, 2010).
- Stimulants
- Executive control problems persist into recovery from methamphetamine; after cocaine, emotional regulation improved by 4 weeks while impulse control had not (SAMHSA, 2010).
- Benzodiazepines
- New anxiety, insomnia, depression, poor concentration, muscle twitches, tingling and ringing in the ears, which can be hard to tell apart from the return of the original condition (FDA, 2020; SAMHSA, 2010).
How long does post-acute withdrawal last?
There is no agreed timeframe for post-acute withdrawal: studies report symptoms lasting weeks to months, and some, such as sleep changes after alcohol, for 1 to 3 years. SAMHSA's advisory gives timeframes for acute withdrawal but declines to give any for protracted withdrawal, because the research is limited and there is no consensus definition (SAMHSA, 2010).
The ranges the sources do report, by substance:
- Alcohol: low mood, anxiety and related symptoms for 4 to 6 months or longer, improving over the early months, with some taking years of abstinence to settle; sleep abnormalities measured in sleep studies for 1 to 3 years (Bahji et al., 2022; SAMHSA, 2010).
- Benzodiazepines: a protracted withdrawal syndrome that persists beyond 4 to 6 weeks, with symptoms lasting weeks to as long as 12 months (FDA, 2020).
- Opioids: anxiety, depression and sleep problems for weeks or months (SAMHSA, 2010).
- Cannabis: sleep difficulties and strange dreams for at least 45 days, the longest any study in the review ran (SAMHSA, 2010).
Data visual
Acute withdrawal ends in days or weeks; lingering symptoms can run for months
Alcohol
Acute: 5 to 7 days. Reported after: low mood and anxiety for 4 to 6 months or longer; sleep changes for 1 to 3 years.
Benzodiazepines
Acute: 1 to 4 weeks (3 to 5 with a taper). Reported after: beyond 4 to 6 weeks, up to 12 months.
Opioids
Acute: 4 to 10 days (methadone 14 to 21). Reported after: weeks or months, no end point given.
Cannabis
Acute: about 5 days. Reported after: sleep problems for at least 45 days, the longest studied.
The course is uneven. SAMHSA notes that some people feel clear for the first month or two of abstinence before unpleasant symptoms return, that protracted benzodiazepine symptoms typically wax and wane, and that others have no lingering symptoms at all (SAMHSA, 2010).

The direction over time is toward improvement: the 2022 review describes near-normalization over the early months of abstinence for most alcohol-related symptoms (Bahji et al., 2022).
Does PAWS raise the risk of relapse?
Lingering withdrawal symptoms are linked to returning to substance use: the 2022 review found that cravings, anhedonia and anxiety in particular may be risk factors for drinking again. SAMHSA explains the mechanism plainly: people may try to relieve the symptoms by using again, at a time when their ability to resist impulses is weaker (Bahji et al., 2022; SAMHSA, 2010).
A risk factor is not a certainty. The same review stresses that the link between PAWS and relapse is still debated, and the studies behind it are small (Bahji et al., 2022). A bad week of sleep or mood is a symptom to manage, not a sign that recovery has failed.
The guides to relapse warning signs and how to deal with cravings in recovery cover what to watch for and what to do in the moment.
What helps with post-acute withdrawal symptoms?
SAMHSA's advisory recommends realistic expectations, good sleep habits, regular physical and mental activity, simple routines and lists, patience, mutual support groups, cognitive behavioral therapy and regular check-ins during continuing care. It frames these as ways to recognize and manage symptoms, not as a cure (SAMHSA, 2010).

Small, repeatable habits carry most of this advice. The following are the practical steps SAMHSA's advisory describes:
- Expect a process. Feeling not fully recovered in the first weeks and months of abstinence is normal; focus on small improvements and count each new coping skill as progress.
- Protect sleep. Go to bed and get up at the same times, exercise early in the day, keep caffeine low, eat well and avoid late-afternoon naps. More in sleep problems in early recovery.
- Stay active. SAMHSA says physical and mental exercise can improve sleep and mood and reduce stress; to-do lists and set daily routines help with memory and focus problems.
- Don't overbook. Trying to make up for lost time raises stress and can make symptoms worse.
- Get support. Mutual support groups, cognitive behavioral therapy for impulse control and problem solving, and regular check-ins with a counselor or clinician.
Medication is a clinical decision. SAMHSA's advisory notes that acamprosate may ease some lingering symptoms after alcohol and that prescribers may consider methadone or buprenorphine treatment when protracted opioid symptoms are too powerful and the risk of relapse is high, and it urges caution with sleep medications because of misuse risk (SAMHSA, 2010). This page gives no medication or dosing advice: talk to a prescriber.
Two related guides cover the first months after treatment: what happens after rehab and the first 30 days in sober living describe how people build a daily routine.
When could lingering symptoms be something else?
Lingering symptoms can also come from a co-occurring mental health condition, such as depression or an anxiety disorder, from a past head injury, from medication side effects or from a return to use, so they need a clinician's assessment rather than a self-label. SAMHSA asks treatment providers to assess and reassess for co-occurring disorders, depression and suicidal thoughts as recovery goes on (SAMHSA, 2010).
Two patterns point away from PAWS. Symptoms that were there before the substance use began, such as long-standing anxiety, and that do not ease with time suggest an underlying condition that needs its own treatment; with benzodiazepines, this is called symptom reemergence. Sleep problems may also come from old sleep habits, stress or medication rather than withdrawal (SAMHSA, 2010).
Get help now
Call 911 for seizures, severe confusion, hallucinations, a fever or trouble breathing (MedlinePlus, 2025; FDA, 2020). If you are thinking about suicide or are in emotional crisis, call or text 988, the 988 Suicide & Crisis Lifeline (SAMHSA, 2025). For treatment referrals, SAMHSA's National Helpline is free, confidential and open 24/7 at 1-800-662-4357 (SAMHSA, 2023).
Post-acute withdrawal syndrome (PAWS): symptoms, timeline and what helps
Worksheet
One-week symptom tracker
Tick each day you notice a symptom, add notes, then print the sheet or save it as a PDF to bring to a counselor or clinician. There is no score: the pattern over the week is the point.
Nothing you tick or type here is saved or sent. This tracker is not a test and gives no diagnosis. Your browser's own print command prints this sheet too.
Source: Post-acute withdrawal syndrome (PAWS): symptoms, timeline and what helps, livesobernj.com/post-acute-withdrawal-syndrome/ (reviewed November 2026). Symptom list from SAMHSA, Protracted Withdrawal (2010). General information, not medical advice; talk to a clinician.Live Sober NJ (201) 231-1066
What does the evidence on PAWS not show?
The evidence on PAWS is thin: it is not a recognized diagnosis in the DSM or the ICD, there is no agreed definition or timeframe, and most of the research is small, dated and about alcohol. The 2022 review found credible evidence for the concept but called it controversial, with no consensus on whether it exists as a distinct syndrome, what causes it or how it affects relapse (Bahji et al., 2022).
Where it can help
- Knowing the pattern sets realistic expectations: feeling not fully recovered in the first months is normal (SAMHSA, 2010).
- It names a high-risk window for returning to use, which can prompt earlier support (Bahji et al., 2022).
- The term points people to practical steps: sleep habits, activity, routines and support (SAMHSA, 2010).
Downsides and limits
- No DSM or ICD diagnosis and no shared definition, so studies measure different things (Bahji et al., 2022).
- Studies are small, many are old, randomized trials are scarce, and only one reviewer screened the 2022 review's studies (Bahji et al., 2022).
- Research on substances other than alcohol is limited (SAMHSA, 2010).
- The symptoms overlap with depression, anxiety disorders and head injury, so calling everything PAWS can delay treatment of a separate condition (SAMHSA, 2010).
- High-quality treatment trials for PAWS are still needed (Bahji et al., 2022).
General information, not medical advice. This page does not diagnose or recommend medication; talk to a clinician about your symptoms.
Questions about post-acute withdrawal
No. PAWS is not a diagnosis in the DSM or the ICD, and researchers have not agreed on a definition. A 2022 systematic review still found credible evidence for the pattern after alcohol (Bahji et al., 2022).
No. Some people have no symptoms after acute withdrawal, others have lingering symptoms, and the intensity differs from person to person (SAMHSA, 2010).
Lingering symptoms are reported after cannabis too. A review of 19 studies cited by SAMHSA found sleep difficulties and strange dreams lasting at least 45 days, the longest any of the studies ran (SAMHSA, 2010).
Sometimes, and only through a prescriber. SAMHSA notes that acamprosate may ease some lingering symptoms after alcohol, and that prescribers may consider methadone or buprenorphine treatment when protracted opioid symptoms are too powerful and the risk of relapse is high (SAMHSA, 2010). This page gives no medication advice; talk to a prescriber.
No. The FDA warns that stopping a benzodiazepine abruptly, or reducing the dose too quickly, can cause withdrawal reactions, including seizures, which can be life-threatening. Plan any taper with your prescriber (FDA, 2020).
Expect good and hard days. SAMHSA asks providers to explain that feeling not fully recovered in the first months is normal and to celebrate small gains; family can do the same and call or text 988 in a crisis (SAMHSA, 2010; SAMHSA, 2025).
Sources
This guide is general information from the sources below, not medical advice.
- Substance Abuse and Mental Health Services Administration (2010). Protracted Withdrawal. Substance Abuse Treatment Advisory, Volume 9, Issue 1, HHS Publication No. (SMA) 10-4554. store.samhsa.gov. Accessed November 1, 2026.
- Bahji, A., Crockford, D. and el-Guebaly, N. (2022). Neurobiology and Symptomatology of Post-Acute Alcohol Withdrawal: A Mixed-Studies Systematic Review. Journal of Studies on Alcohol and Drugs, 83(4), 461-469. pmc.ncbi.nlm.nih.gov. Accessed November 1, 2026.
- U.S. Food and Drug Administration (2020). FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class, Drug Safety Communication, September 23, 2020. fda.gov. Accessed November 1, 2026.
- National Library of Medicine, MedlinePlus (2025). Alcohol withdrawal, reviewed January 1, 2025. medlineplus.gov. Accessed November 1, 2026.
- National Library of Medicine, MedlinePlus (2026). Opiate and opioid withdrawal, reviewed May 15, 2026. medlineplus.gov. Accessed November 1, 2026.
- Substance Abuse and Mental Health Services Administration (2023). SAMHSA's National Helpline. samhsa.gov. Accessed November 1, 2026.
- Substance Abuse and Mental Health Services Administration (2025). 988 Suicide & Crisis Lifeline. samhsa.gov. Accessed November 1, 2026.